Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:2581-2586
Published online before print May 3, 2004, doi: 10.1161/01.CIR.0000129771.32215.44
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/21/2581    most recent
01.CIR.0000129771.32215.44v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshioka, J.
Right arrow Articles by Lee, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshioka, J.
Right arrow Articles by Lee, R. T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENYLEPHRINE
Related Collections
Right arrow Hypertrophy
Right arrow Oxidant stress

(Circulation. 2004;109:2581-2586.)
© 2004 American Heart Association, Inc.


Basic Science Reports

Thioredoxin-Interacting Protein Controls Cardiac Hypertrophy Through Regulation of Thioredoxin Activity

Jun Yoshioka, MD, PhD; P. Christian Schulze, MD, PhD; Mihaela Cupesi, MD; Jeremy D. Sylvan, BS; Catherine MacGillivray, AD; Joseph Gannon; Hayden Huang, PhD; Richard T. Lee, MD

From the Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Richard T. Lee, MD, 65 Landsdowne St, No. 279, Cambridge, MA 02139. E-mail rlee{at}rics.bwh.harvard.edu

Received September 2, 2003; de novo received December 29, 2003; accepted February 4, 2004.

Background— Although cellular redox balance plays an important role in mechanically induced cardiac hypertrophy, the mechanisms of regulation are incompletely defined. Because thioredoxin is a major intracellular antioxidant and can also regulate redox-dependent transcription, we explored the role of thioredoxin activity in mechanically overloaded cardiomyocytes in vitro and in vivo.

Methods and Results— Overexpression of thioredoxin induced protein synthesis in cardiomyocytes (127±5% of controls, P<0.01). Overexpression of thioredoxin-interacting protein (Txnip), an endogenous thioredoxin inhibitor, reduced protein synthesis in response to mechanical strain (89±5% reduction, P<0.01), phenylephrine (80±3% reduction, P<0.01), or angiotensin II (80±4% reduction, P<0.01). In vivo, myocardial thioredoxin activity increased 3.5-fold compared with sham controls after transverse aortic constriction (P<0.01). Aortic constriction did not change thioredoxin expression but reduced Txnip expression by 40% (P<0.05). Gene transfer studies showed that cells that overexpress Txnip develop less hypertrophy after aortic constriction than control cells in the same animals (28.1±5.2% reduction versus noninfected cells, P<0.01).

Conclusions— Thus, even though thioredoxin is an antioxidant, activation of thioredoxin participates in the development of pressure-overload cardiac hypertrophy, demonstrating the dual function of thioredoxin as both an antioxidant and a signaling protein. These results also support the emerging concept that the thioredoxin inhibitor Txnip is a critical regulator of biomechanical signaling.


Key Words: hypertrophy • mechanics • stress




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Li, K. Tang, B. Xie, S. Li, and G. J. Rozanski
Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H416 - H424.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Davis
Searching for Causality of Knocking Out Txnip: Is Txnip Missing in Action?
Circ. Res., December 7, 2007; 101(12): 1216 - 1218.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Yoshioka, K. Imahashi, S. A. Gabel, W. A. Chutkow, A. A. Burds, J. Gannon, P. C. Schulze, C. MacGillivray, R. E. London, E. Murphy, et al.
Targeted Deletion of Thioredoxin-Interacting Protein Regulates Cardiac Dysfunction in Response to Pressure Overload
Circ. Res., December 7, 2007; 101(12): 1328 - 1338.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. K.C. Ng, J. Wu, E. Chang, B.-y. Wang, R. Katzenberg-Clark, A. Ishii-Watabe, and J. P. Cooke
A Central Role for Nicotinic Cholinergic Regulation of Growth Factor-Induced Endothelial Cell Migration
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 106 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Patwari, L. J. Higgins, W. A. Chutkow, J. Yoshioka, and R. T. Lee
The Interaction of Thioredoxin with Txnip: EVIDENCE FOR FORMATION OF A MIXED DISULFIDE BY DISULFIDE EXCHANGE
J. Biol. Chem., August 4, 2006; 281(31): 21884 - 21891.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Jeong, H. Cha, E. Kim, M. Kang, D. K. Yang, J. M. Kim, P. O. Yoon, J. G. Oh, O. Y. Bernecker, S. Sakata, et al.
PICOT Inhibits Cardiac Hypertrophy and Enhances Ventricular Function and Cardiomyocyte Contractility
Circ. Res., August 4, 2006; 99(3): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. E. Filby, S. B. Hooper, F. Sozo, V. A. Zahra, S. J. Flecknoe, and M. J. Wallace
VDUP1: a potential mediator of expansion-induced lung growth and epithelial cell differentiation in the ovine fetus
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L250 - L258.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Fan, D. A. Iacobas, D. Zhou, Q. Chen, J. K. Lai, O. Gavrialov, and G. G. Haddad
Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia
Physiol Genomics, August 11, 2005; 22(3): 292 - 307.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yoshioka, R. N. Prince, H. Huang, S. B. Perkins, F. U. Cruz, C. MacGillivray, D. A. Lauffenburger, and R. T. Lee
Cardiomyocyte hypertrophy and degradation of connexin43 through spatially restricted autocrine/paracrine heparin-binding EGF
PNAS, July 26, 2005; 102(30): 10622 - 10627.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. M. Kuster, D. R. Pimentel, T. Adachi, Y. Ido, D. A. Brenner, R. A. Cohen, R. Liao, D. A. Siwik, and W. S. Colucci
{alpha}-Adrenergic Receptor-Stimulated Hypertrophy in Adult Rat Ventricular Myocytes Is Mediated via Thioredoxin-1-Sensitive Oxidative Modification of Thiols on Ras
Circulation, March 8, 2005; 111(9): 1192 - 1198.
[Abstract] [Full Text] [PDF]